Surprisingly, we found that male C57BL/6 WT mice had a 50% higher SERT BMAX than female WT mice of this strain, so it seems that elevated SERT BMAX does not predispose male mice to the development of dexfenfluramine-induced PAH. The gene discussed is SLC6A4; the disease is pulmonary arterial hypertension.